Group psychedelic therapy
Empirical estimates of cost-savings and improved access
Bibliographic Data
| ID | 15516909 |
|---|---|
| Authors | Elliot Marseille (0000-0001-8518-1143, Berkeley Public Health Division, corresponding author), Christopher S Stauffer (0000-0002-0888-095X, Oregon Health & Science University), Manish Agrawal (0000-0001-7447-2367), Paul Thambi, Kimberly Roddy, Michael C Mithoefer (0000-0002-4267-6135, Medical University of South Carolina), Michael Mithoefer, Stefano Bertozzi (0000-0002-1723-7085, University of California, Berkeley), Stefano M Bertozzi, James G Kahn (0000-0002-1259-7233, University of California, San Francisco) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1293243-1293243 |
| Publication date | 2023-12-06 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1293243 |
| PMID | 38125286 |
| OpenAlex | W4389392873 |
| Language | EN |
| Citations received | 8 |
| References cited | 19 |
Adopting group therapy protocols where feasible would significantly reduce the cost of psychedelic-assisted therapies. By enhancing the number of patients served per clinician, group therapy could also ameliorate the anticipated shortage of appropriately trained clinicians, thereby accelerating access to these promising new therapies
Anxiety · Exposure therapy · Group psychotherapy · Hallucinogen · Major depressive disorder · MDMA · Mood · Psilocybin · Psychiatry · Chemical synthesis and alkaloids · Complementary and Alternative Medicine Studies · Medicine · Psychedelics and Drug Studies
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience
Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico
Psychedelics beyond medicine
Ketamine-Assisted Psychotherapy for Depression
Becoming a Psychedelic User
LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being
Ketamine-assisted group psychotherapy integrating cognitive processing therapy to address identity-based trauma
Low-income group psilocybin assisted therapy for depression
Methods for the Economic Evaluation of Health Care Programmes
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
MDMA-assisted therapy for severe PTSD
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Long-term follow-up of psilocybin-facilitated smoking cessation
Trial of Psilocybin versus Escitalopram for Depression
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders
Psychedelic-Assisted Group Therapy
| Citations per year | 8 |
|---|---|
| Citation span | 2025 - 2026 (2) |
| Highly cited | No |